CME Group (NASDAQ:CME) Price Target Raised to $300.00 at Oppenheimer

CME Group (NASDAQ:CME - Get Free Report) had its target price hoisted by equities researchers at Oppenheimer from $282.00 to $300.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the financial services provider's stock. Oppenheimer's target price would indicate a potential upside of 9.13% from the stock's current price.

A number of other equities research analysts also recently commented on the stock. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. JPMorgan Chase & Co. reduced their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, UBS Group increased their target price on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $258.20.

CME Group Trading Down 1.1%

Shares of CME traded down $2.98 during mid-day trading on Wednesday, reaching $274.90. The stock had a trading volume of 1,957,832 shares, compared to its average volume of 2,186,594. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business's fifty day moving average is $271.26 and its 200 day moving average is $252.28. CME Group has a 52-week low of $190.70 and a 52-week high of $290.79. The firm has a market cap of $99.06 billion, a price-to-earnings ratio of 28.43, a P/E/G ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm earned $2.50 earnings per share. The firm's revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts predict that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity

In other news, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the transaction, the director now directly owns 3,668 shares of the company's stock, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. The trade was a 31.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 22,900 shares of company stock worth $6,147,935. 0.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On CME Group

Hedge funds have recently made changes to their positions in the business. Wayfinding Financial LLC acquired a new stake in CME Group in the first quarter worth about $25,000. Cornerstone Planning Group LLC grew its position in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC increased its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 98 shares during the period. Ransom Advisory Ltd bought a new stake in shares of CME Group in the 1st quarter worth $31,000. Finally, Alpine Bank Wealth Management acquired a new stake in shares of CME Group in the first quarter valued at $32,000. Institutional investors own 87.75% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.